Here to help you get the Rituxan your doctor prescribed.
This is not an actual patient. For illustrative purposes only based on the results of the PV study.
If you have moderate to severe pemphigus vulgaris (PV),
A study of people with PV showed that 9 out of 10 of those treated with Rituxan had no lesions at 2 years compared to 3 out of 10 people treated with only steroids
Individual results may vary.
This is not an actual patient. For illustrative purposes only based on the results of the PV study.
If you have moderate to severe pemphigus vulgaris (PV),
A study of people with PV showed that 9 out of 10 of those treated with Rituxan had no lesions at 2 years compared to 3 out of 10 people treated with only steroids
Individual results may vary.
Patients were given European Union–approved rituximab + short-term steroids in a clinical study to measure their lesion improvement
*The generic name for Rituxan is rituximab.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.